A Phase I Study of Adenovirus Mediated Gene Transfer of Interleukin 2 cDNA into Metastatic Breast Cancer or Melanoma. The Toronto Hospital, Toronto, Ontario, Canada
- 20 July 1997
- journal article
- clinical trial
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 8 (11) , 1403-1414
- https://doi.org/10.1089/hum.1997.8.11-1403
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.Proceedings of the National Academy of Sciences, 1994
- CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinomaNature, 1994
- Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell LinesScience, 1994
- T-cell antigens in cancer.Proceedings of the National Academy of Sciences, 1994
- Genes Coding for Tumor Antigens Recognized by Human Cytolytic T LymphocytesJournal of Immunotherapy, 1993
- Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma CellsScience, 1993
- Intratumoral rIL2-based immunotherapy in B16 melanomaJournal of Surgical Research, 1992
- B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.Proceedings of the National Academy of Sciences, 1991
- Adenovirus-Mediated Transfer of a Recombinant α1-Antitrypsin Gene to the Lung Epithelium in VivoScience, 1991
- Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation. Studies on the mechanism of action.The Journal of Experimental Medicine, 1990